Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Published:2021-11 Issue:11 Volume:2 Page:1224-1242
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Lehtiö Janne^ORCID,Arslan Taner^ORCID,Siavelis Ioannis,Pan Yanbo^ORCID,Socciarelli Fabio,Berkovska Olena^ORCID,Umer Husen M.,Mermelekas Georgios,Pirmoradian Mohammad,Jönsson Mats,Brunnström Hans^ORCID,Brustugun Odd Terje,Purohit Krishna Pinganksha,Cunningham Richard,Foroughi Asl Hassan,Isaksson Sofi,Arbajian Elsa,Aine Mattias^ORCID,Karlsson Anna^ORCID,Kotevska Marija,Gram Hansen Carsten,Drageset Haakensen Vilde,Helland Åslaug,Tamborero David,Johansson Henrik J.^ORCID,Branca Rui M.,Planck Maria,Staaf Johan^ORCID,Orre Lukas M.

Funder

Vetenskapsrådet

Cancerfonden

Stiftelsen för Strategisk Forskning

Familjen Erling-Perssons Stiftelse

EC | Horizon 2020 Framework Programme

Radiumhemmets Forskningsfonder

Karolinska Institutet

University of Edinburgh

Worldwide Cancer Research

the Sjöberg Foundation

Fru Berta Kamprads Stiftelse

Lunds Universitet

Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-021-00259-9.pdf

Reference74 articles.

1. Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012).

2. Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543–550 (2014).

3. Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884–901 (2010).

4. Stewart, P. A. et al. Proteogenomic landscape of squamous cell lung cancer. Nat. Commun. 10, 3578 (2019).

5. Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200–225 (2020).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissecting transcriptome signals of anti-PD-1 response in lung adenocarcinoma;Scientific Reports;2024-09-10

2. Comparative analysis of transcriptomic and proteomic expression between two non-small cell lung cancer subtypes;2024-09-10

3. PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up;Oncogene;2024-08-15

4. Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges;International Journal of Molecular Sciences;2024-08-14

5. Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry–Based Proteomics;Molecular & Cellular Proteomics;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3